GFAP and Alzheimer disease: GFAP is the primary intermediate filament protein in astrocytes (Middeldorp and Hol, 2011), and its upregulation reflects astrocytic activation and neuroinflammation severity in the AD brain, which in turn is an indicator of pathological progression (Li et al., 2011; Arranz and de Strooper, 2019).